CIK 0001022899 · Non-accelerated filer<br>Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061390025
- Phone
- (212) 994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- SC 13D Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Auditor change
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Unregistered share sale · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change
- SC 14F1 Other SC 14F1
- 8-K Event Material agreement · Bylaws or fiscal year change
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Bylaws or fiscal year change
- 10QSB Other 10QSB
- 8-K Event Other events
- 10KSB Other 10KSB
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- NTN 10K Other NTN 10K
- 8-K Event Material agreement · Unregistered share sale · Change in control · Executive or director change
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 31 of 36 · 707 filings